Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose oral prednisone for prevention of post-traumatic stress disorder
MOH_2024-07-29_013555Phase 3Recruiting
- Sponsor
- ד"ר משה איסרלס
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of prednisone in post-traumatic stress disorder (PTSD), sponsored by ד"ר משה איסרלס. Started Oct 2023; status: recruiting.
02
Drugs
prednisone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on MOH_2024-07-29_013555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-07-29_013555.